Padcev

PADCEV® (enfortumab vedotin-ejfv) is a prescription medicine used to treat advanced bladder cancer and certain urinary tract cancers. It can be used alone or with pembrolizumab and is intended for patients who have received prior therapies. PADCEV has shown improved survival outcomes and offers patient support programs.